Walt Disney stock had magical week off strong quarterly results

May 10, 2015 at 12:17AM

Mickey's magic: Walt Disney's stock hit an all-time high Tuesday after it delivered quarterly results that beat Wall Street's estimates, thanks, in part, to rising revenue from its Walt Disney World Resort and other theme parks. Disney's stock climbed 1 percent, to $111.69. It closed the week at $110.11.

Earnings bounce: Shares in Cognizant Technology Solutions rose 9 percent Monday, to $63.25, after the New Jersey-based company reported earnings that beat the expectations of Wall Street analysts and raised its earnings and sales outlook for the year. Shares closed the week at $63.09.

Profit surge: Video game maker Electronic Arts, maker of the Madden NFL and Battlefield games, rose 6 percent Wednesday to $62.49 after its quarterly earnings easily beat estimates thanks in part to strong catalog sales and a bullish revenue outlook. Shares closed Friday at $61.88.

Drug boost: Shares of Synageva BioPharma soared 115 percent, to $206.30, on Wednesday after Alexion Pharmaceuticals said it would pay a huge premium to buy the maker of rare disease treatments in an $8.4 billion deal. Synageva has no products on the market and lost nearly $60 million in the first quarter. Its shares closed the week at $213.90.

Monster day: Monster Beverage Corp. shares on Friday declined the most in more than two years after its distribution deal with Coca-Cola Co. took a toll on profit in the first quarter, when the company had to cancel contracts with other partners. Net income fell to $4.41 million, or 3 cents a share, from $95.3 million, or 55 cents, a year earlier. The stock fell 10 percent to $128.47, the biggest one-day decline since October 2012.

NEWS SERVICES

about the writer

about the writer

More from Business

See More
card image
Fairview Health Services

The school is changing an elective course while still working with the Eden Prairie-based health care giant after students raised concerns.

This transmission electron microscope image shows SARS-CoV-2, the virus that causes COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab. (NIAID/TNS) ORG XMIT: 1659810
card image